Recurrent disease after pediatric renal transplantation.

Background: Recurrent disease after kidney transplant remains an important cause of allograft failure, accounting for 7‐8% of graft loss and ranking as the fifth most common cause of allograft loss in the pediatric population. Although the pathophysiology of many recurrent diseases is incompletely understood, recent advances in basic science and therapeutics are improving outcomes and changing the course of several of these conditions. Methods: Review of the literature. Results: We discuss the diagnosis and management of recurrent disease. Conclusion: We highlight new insights into the pathophysiology and treatment of post‐transplant primary hyperoxaluria, focal segmental glomerulosclerosis, immune complex glomerulonephritis, C3 glomerulopathy, lupus nephritis, atypical hemolytic uremic syndrome, and IgA nephropathy. [ABSTRACT FROM AUTHOR]